Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, flags an important opportunity for MedTech suppliers to engage with government on preparation for the introduction of value based procurement. The Department of Health and So
The UK has a unique asset: millions of longitudinal health records built over decades across a diverse population. From births and vaccinations to cancer diagnoses and mental health treatments, this data holds extraordinary potential to improve medical research and accelerate the development of new
Healthcare systems are essential for protecting human health, yet they also generate substantial amounts of plastic waste. Medical packaging, designed to ensure sterility and patient safety, relies heavily on materials such as polyethylene (PE) and polypropylene (PP). Although these plastics are tec
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, points to a new challenge to the MedTech sector of deliver devices to tackle substance addiction. The UK government has opened a major new funding opportunity for innovators
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, reviews the trends from the latest approvals data from the medical devices regulator. The UK’s medical device sector is entering a period of unprecedented momentum, with new
For many MedTech and digital health innovators, international expansion feels like a natural next step. New markets promise larger patient populations, new customers, and new and larger opportunities for growth. However, the reality of entering global healthcare systems is rarely straightforward. Ea
MD&M West took place from February 3-5, 2026 in Anaheim, California, with over 1,700 exhibitors and an estimated 13,000+ attendees. I was on site at the event, talking to a range of companies about the latest developments in medical device manufacturing. Over a series of 13 interviews, I spoke to en
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, identifies a new consultation launched by the UK’s MedTech regulator. The Medicines and Healthcare products Regulatory Agency (MHRA) has launched a public consultation on pro
“Running a system as large and complex as the NHS centrally is an experiment which has run its course.” The MTG sat down with Sebastian Rees, Head of Health at the IPPR (Institute for Public Policy Research) to discuss our new report on accountability. From the Ten Year Health Plan to the abolition
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, reports on the latest steps by government agencies to drive the adoption of innovative MedTech. Medical device innovators across the UK are set to benefit from a major shift
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, highlights the latest efforts by government and its agencies to engage with MedTech suppliers, SMEs and their trade associations. The Department of Health and Social Care (DH
Editor Oli Johnson speaks to BioInteractions Commercial Director Arjun Luthra at MD&M West about the company’s portfolio of coatings, particularly its Assist product, which it highlighted at the show.
